nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—Vasopressin regulates renal water homeostasis via Aquaporins—GNAS—peripheral nervous system neoplasm	0.0038	0.0679	CbGpPWpGaD
Acetazolamide—AQP1—Aquaporin-mediated transport—GNAS—peripheral nervous system neoplasm	0.00331	0.0593	CbGpPWpGaD
Acetazolamide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00272	0.00288	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.00269	0.00285	CcSEcCtD
Acetazolamide—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00262	0.00277	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00259	0.00274	CcSEcCtD
Acetazolamide—Melaena—Epirubicin—peripheral nervous system neoplasm	0.00256	0.00271	CcSEcCtD
Acetazolamide—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00255	0.0027	CcSEcCtD
Acetazolamide—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.00254	0.00269	CcSEcCtD
Acetazolamide—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00253	0.00268	CcSEcCtD
Acetazolamide—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00253	0.00268	CcSEcCtD
Acetazolamide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00252	0.00267	CcSEcCtD
Acetazolamide—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.0025	0.00265	CcSEcCtD
Acetazolamide—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.0025	0.00265	CcSEcCtD
Acetazolamide—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.0025	0.00265	CcSEcCtD
Acetazolamide—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00249	0.00264	CcSEcCtD
Acetazolamide—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.00262	CcSEcCtD
Acetazolamide—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00248	0.00262	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.00247	0.00262	CcSEcCtD
Acetazolamide—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00247	0.00261	CcSEcCtD
Acetazolamide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00246	0.0026	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00245	0.00259	CcSEcCtD
Acetazolamide—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00245	0.00259	CcSEcCtD
Acetazolamide—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00245	0.00259	CcSEcCtD
Acetazolamide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00245	0.00259	CcSEcCtD
Acetazolamide—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00245	0.00259	CcSEcCtD
Acetazolamide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00244	0.00258	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00243	0.00257	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00243	0.00257	CcSEcCtD
Acetazolamide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00243	0.00257	CcSEcCtD
Acetazolamide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00243	0.00257	CcSEcCtD
Acetazolamide—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00242	0.00257	CcSEcCtD
Acetazolamide—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00241	0.00256	CcSEcCtD
Acetazolamide—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.0024	0.00254	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.0024	0.00254	CcSEcCtD
Acetazolamide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.0024	0.00254	CcSEcCtD
Acetazolamide—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00239	0.00253	CcSEcCtD
Acetazolamide—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00237	0.00251	CcSEcCtD
Acetazolamide—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00237	0.00251	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—peripheral nervous system neoplasm	0.00236	0.0025	CcSEcCtD
Acetazolamide—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00236	0.0025	CcSEcCtD
Acetazolamide—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00234	0.00248	CcSEcCtD
Acetazolamide—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00233	0.00247	CcSEcCtD
Acetazolamide—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00232	0.00246	CcSEcCtD
Acetazolamide—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.00246	CcSEcCtD
Acetazolamide—Agitation—Vincristine—peripheral nervous system neoplasm	0.00231	0.00245	CcSEcCtD
Acetazolamide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00227	0.00241	CcSEcCtD
Acetazolamide—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.0024	CcSEcCtD
Acetazolamide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00225	0.00239	CcSEcCtD
Acetazolamide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00225	0.00239	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00225	0.00239	CcSEcCtD
Acetazolamide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00224	0.00238	CcSEcCtD
Acetazolamide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00224	0.00237	CcSEcCtD
Acetazolamide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00224	0.00237	CcSEcCtD
Acetazolamide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00222	0.00236	CcSEcCtD
Acetazolamide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00222	0.00236	CcSEcCtD
Acetazolamide—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00222	0.00235	CcSEcCtD
Acetazolamide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00221	0.00234	CcSEcCtD
Acetazolamide—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.0022	0.00233	CcSEcCtD
Acetazolamide—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00218	0.00231	CcSEcCtD
Acetazolamide—Flushing—Etoposide—peripheral nervous system neoplasm	0.00217	0.0023	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00217	0.0023	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00216	0.00229	CcSEcCtD
Acetazolamide—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00228	CcSEcCtD
Acetazolamide—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00213	0.00226	CcSEcCtD
Acetazolamide—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.00211	0.00224	CcSEcCtD
Acetazolamide—Shock—Alitretinoin—peripheral nervous system neoplasm	0.0021	0.00222	CcSEcCtD
Acetazolamide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00209	0.00221	CcSEcCtD
Acetazolamide—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00207	0.00219	CcSEcCtD
Acetazolamide—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00206	0.00218	CcSEcCtD
Acetazolamide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00204	0.00216	CcSEcCtD
Acetazolamide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00214	CcSEcCtD
Acetazolamide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00214	CcSEcCtD
Acetazolamide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00201	0.00213	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00201	0.00213	CcSEcCtD
Acetazolamide—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00201	0.00213	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.002	0.00212	CcSEcCtD
Acetazolamide—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.002	0.00212	CcSEcCtD
Acetazolamide—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.002	0.00212	CcSEcCtD
Acetazolamide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00199	0.00211	CcSEcCtD
Acetazolamide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00199	0.00211	CcSEcCtD
Acetazolamide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00198	0.0021	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00196	0.00208	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.00196	0.00207	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00206	CcSEcCtD
Acetazolamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00194	0.00206	CcSEcCtD
Acetazolamide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00193	0.00204	CcSEcCtD
Acetazolamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.00204	CcSEcCtD
Acetazolamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00193	0.00204	CcSEcCtD
Acetazolamide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.00203	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00191	0.00202	CcSEcCtD
Acetazolamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.0019	0.00201	CcSEcCtD
Acetazolamide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00201	CcSEcCtD
Acetazolamide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.0019	0.00201	CcSEcCtD
Acetazolamide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00189	0.002	CcSEcCtD
Acetazolamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.00199	CcSEcCtD
Acetazolamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00188	0.00199	CcSEcCtD
Acetazolamide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00187	0.00198	CcSEcCtD
Acetazolamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00186	0.00197	CcSEcCtD
Acetazolamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.00197	CcSEcCtD
Acetazolamide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00196	CcSEcCtD
Acetazolamide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00185	0.00195	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00195	CcSEcCtD
Acetazolamide—Malaise—Etoposide—peripheral nervous system neoplasm	0.00184	0.00195	CcSEcCtD
Acetazolamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00195	CcSEcCtD
Acetazolamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00183	0.00193	CcSEcCtD
Acetazolamide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00182	0.00193	CcSEcCtD
Acetazolamide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00182	0.00193	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00182	0.00192	CcSEcCtD
Acetazolamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.0018	0.00191	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.00191	CcSEcCtD
Acetazolamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00179	0.0019	CcSEcCtD
Acetazolamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00179	0.0019	CcSEcCtD
Acetazolamide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00179	0.00189	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00189	CcSEcCtD
Acetazolamide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00178	0.00188	CcSEcCtD
Acetazolamide—Headache—Topotecan—peripheral nervous system neoplasm	0.00178	0.00188	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00177	0.00188	CcSEcCtD
Acetazolamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00177	0.00188	CcSEcCtD
Acetazolamide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00177	0.00187	CcSEcCtD
Acetazolamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00177	0.00187	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00187	CcSEcCtD
Acetazolamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00176	0.00187	CcSEcCtD
Acetazolamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00176	0.00187	CcSEcCtD
Acetazolamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00186	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00173	0.00183	CcSEcCtD
Acetazolamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00172	0.00182	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00171	0.00181	CcSEcCtD
Acetazolamide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00179	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.00169	0.0302	CbGpPWpGaD
Acetazolamide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00169	0.00179	CcSEcCtD
Acetazolamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00169	0.00179	CcSEcCtD
Acetazolamide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00168	0.00178	CcSEcCtD
Acetazolamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00167	0.00177	CcSEcCtD
Acetazolamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.00177	CcSEcCtD
Acetazolamide—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00166	0.00176	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00175	CcSEcCtD
Acetazolamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00165	0.00175	CcSEcCtD
Acetazolamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00165	0.00175	CcSEcCtD
Acetazolamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00173	CcSEcCtD
Acetazolamide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00163	0.00173	CcSEcCtD
Acetazolamide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00162	0.00172	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.00169	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00168	CcSEcCtD
Acetazolamide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00158	0.00167	CcSEcCtD
Acetazolamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00157	0.00167	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00166	CcSEcCtD
Acetazolamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00162	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.0015	0.00159	CcSEcCtD
Acetazolamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.0015	0.00159	CcSEcCtD
Acetazolamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.0015	0.00158	CcSEcCtD
Acetazolamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00148	0.00157	CcSEcCtD
Acetazolamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00147	0.00156	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00155	CcSEcCtD
Acetazolamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00146	0.00155	CcSEcCtD
Acetazolamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00155	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00154	CcSEcCtD
Acetazolamide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00145	0.00153	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00144	0.00152	CcSEcCtD
Acetazolamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00152	CcSEcCtD
Acetazolamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00144	0.00152	CcSEcCtD
Acetazolamide—CA1—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.00142	0.0254	CbGpPWpGaD
Acetazolamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00149	CcSEcCtD
Acetazolamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00141	0.00149	CcSEcCtD
Acetazolamide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.0014	0.00148	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00147	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00138	0.00147	CcSEcCtD
Acetazolamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00137	0.00145	CcSEcCtD
Acetazolamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00137	0.00145	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00145	CcSEcCtD
Acetazolamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Acetazolamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00144	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00143	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00142	CcSEcCtD
Acetazolamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00142	CcSEcCtD
Acetazolamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00132	0.0014	CcSEcCtD
Acetazolamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Acetazolamide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Acetazolamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Acetazolamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00138	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00137	CcSEcCtD
Acetazolamide—Headache—Vincristine—peripheral nervous system neoplasm	0.00129	0.00136	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00136	CcSEcCtD
Acetazolamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00134	CcSEcCtD
Acetazolamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00124	0.00132	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00132	CcSEcCtD
Acetazolamide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00122	0.0013	CcSEcCtD
Acetazolamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00122	0.00129	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00129	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00128	CcSEcCtD
Acetazolamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00119	0.00127	CcSEcCtD
Acetazolamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00122	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00122	CcSEcCtD
Acetazolamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00114	0.00121	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.0012	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00119	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00119	CcSEcCtD
Acetazolamide—AQP1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00112	0.02	CbGpPWpGaD
Acetazolamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.0011	0.00117	CcSEcCtD
Acetazolamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00114	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00107	0.0192	CbGpPWpGaD
Acetazolamide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00112	CcSEcCtD
Acetazolamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00106	0.00112	CcSEcCtD
Acetazolamide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00111	CcSEcCtD
Acetazolamide—Headache—Etoposide—peripheral nervous system neoplasm	0.00104	0.0011	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.0011	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00109	CcSEcCtD
Acetazolamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00108	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.00102	0.0182	CbGpPWpGaD
Acetazolamide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000991	0.00105	CcSEcCtD
Acetazolamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000989	0.00105	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000982	0.00104	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000972	0.00103	CcSEcCtD
Acetazolamide—CA3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000968	0.0173	CbGpPWpGaD
Acetazolamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000962	0.00102	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000954	0.00101	CcSEcCtD
Acetazolamide—CA9—Cellular responses to stress—EED—peripheral nervous system neoplasm	0.00095	0.017	CbGpPWpGaD
Acetazolamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000947	0.001	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000941	0.000997	CcSEcCtD
Acetazolamide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000933	0.000989	CcSEcCtD
Acetazolamide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000918	0.000973	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000917	0.000971	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000914	0.000968	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00089	0.000943	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000871	0.000922	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000864	0.000915	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00085	0.0009	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000846	0.000896	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000845	0.0151	CbGpPWpGaD
Acetazolamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000838	0.000888	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00083	0.000879	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000822	0.00087	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000811	0.000859	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000806	0.000853	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000805	0.000852	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000803	0.0144	CbGpPWpGaD
Acetazolamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000775	0.000821	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000769	0.000815	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.000813	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00076	0.000805	CcSEcCtD
Acetazolamide—CA9—Cellular responses to stress—SUZ12—peripheral nervous system neoplasm	0.00076	0.0136	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000754	0.0135	CbGpPWpGaD
Acetazolamide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000751	0.000795	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.00079	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000745	0.000789	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000741	0.000785	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000738	0.000781	CcSEcCtD
Acetazolamide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000731	0.0131	CbGpPWpGaD
Acetazolamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000712	0.000754	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000686	0.000727	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000683	0.000723	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00067	0.000709	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000659	0.0118	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000654	0.0117	CbGpPWpGaD
Acetazolamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000676	CcSEcCtD
Acetazolamide—CA14—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000624	0.0112	CbGpPWpGaD
Acetazolamide—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000621	0.0111	CbGpPWpGaD
Acetazolamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00062	0.000656	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000617	0.000654	CcSEcCtD
Acetazolamide—CA6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000608	0.0109	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000608	0.0109	CbGpPWpGaD
Acetazolamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000629	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.000626	CcSEcCtD
Acetazolamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000585	0.000619	CcSEcCtD
Acetazolamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000605	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000569	0.0102	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000568	0.0102	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000568	0.0102	CbGpPWpGaD
Acetazolamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000587	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000582	CcSEcCtD
Acetazolamide—AQP1—Metabolism—GNS—peripheral nervous system neoplasm	0.000545	0.00975	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000542	0.00968	CbGpPWpGaD
Acetazolamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.000573	CcSEcCtD
Acetazolamide—CA12—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000526	0.00941	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—NME1—peripheral nervous system neoplasm	0.000523	0.00935	CbGpPWpGaD
Acetazolamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000543	CcSEcCtD
Acetazolamide—AQP1—Metabolism—COX2—peripheral nervous system neoplasm	0.000503	0.009	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GNS—peripheral nervous system neoplasm	0.000473	0.00846	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000458	0.00818	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—NME1—peripheral nervous system neoplasm	0.000453	0.00811	CbGpPWpGaD
Acetazolamide—AQP1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000449	0.00803	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000441	0.00788	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—COX2—peripheral nervous system neoplasm	0.000436	0.0078	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000422	0.00754	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000419	0.0075	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000411	0.00735	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000411	0.00735	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000402	0.00719	CbGpPWpGaD
Acetazolamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.0004	0.00715	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000386	0.00689	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000384	0.00686	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000384	0.00686	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000355	0.00635	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000339	0.00606	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	0.000333	0.00596	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—ENO2—peripheral nervous system neoplasm	0.00033	0.00591	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000321	0.00573	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GNS—peripheral nervous system neoplasm	0.000305	0.00545	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000299	0.00534	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GNS—peripheral nervous system neoplasm	0.000297	0.00531	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GNS—peripheral nervous system neoplasm	0.000297	0.00531	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NME1—peripheral nervous system neoplasm	0.000292	0.00522	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ENO2—peripheral nervous system neoplasm	0.000287	0.00512	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NME1—peripheral nervous system neoplasm	0.000285	0.00509	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NME1—peripheral nervous system neoplasm	0.000285	0.00509	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000283	0.00507	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—COX2—peripheral nervous system neoplasm	0.000281	0.00503	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000279	0.00499	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GNS—peripheral nervous system neoplasm	0.000277	0.00496	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GNS—peripheral nervous system neoplasm	0.000277	0.00496	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—COX2—peripheral nervous system neoplasm	0.000274	0.0049	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—COX2—peripheral nervous system neoplasm	0.000274	0.0049	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000272	0.00486	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000266	0.00476	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NME1—peripheral nervous system neoplasm	0.000266	0.00475	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NME1—peripheral nervous system neoplasm	0.000266	0.00475	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—TH—peripheral nervous system neoplasm	0.000263	0.00469	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00026	0.00466	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GNS—peripheral nervous system neoplasm	0.000257	0.00459	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—COX2—peripheral nervous system neoplasm	0.000256	0.00458	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—COX2—peripheral nervous system neoplasm	0.000256	0.00458	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NME1—peripheral nervous system neoplasm	0.000246	0.0044	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—BCHE—peripheral nervous system neoplasm	0.000242	0.00433	CbGpPWpGaD
Acetazolamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000241	0.00431	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—COX2—peripheral nervous system neoplasm	0.000237	0.00424	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000235	0.0042	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000231	0.00413	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.00023	0.00411	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000229	0.00409	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—TH—peripheral nervous system neoplasm	0.000228	0.00407	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.000221	0.00395	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000214	0.00383	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00021	0.00376	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GNS—peripheral nervous system neoplasm	0.000205	0.00366	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000204	0.00364	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GNS—peripheral nervous system neoplasm	0.000196	0.00351	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NME1—peripheral nervous system neoplasm	0.000196	0.00351	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000196	0.0035	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—COX2—peripheral nervous system neoplasm	0.000189	0.00338	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GNS—peripheral nervous system neoplasm	0.000188	0.00337	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NME1—peripheral nervous system neoplasm	0.000188	0.00337	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GNAS—peripheral nervous system neoplasm	0.000186	0.00332	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ENO2—peripheral nervous system neoplasm	0.000185	0.0033	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000182	0.00326	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—COX2—peripheral nervous system neoplasm	0.000181	0.00324	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NME1—peripheral nervous system neoplasm	0.000181	0.00323	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ENO2—peripheral nervous system neoplasm	0.00018	0.00322	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ENO2—peripheral nervous system neoplasm	0.00018	0.00322	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—COX2—peripheral nervous system neoplasm	0.000174	0.00311	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ENO2—peripheral nervous system neoplasm	0.000168	0.003	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ENO2—peripheral nervous system neoplasm	0.000168	0.003	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GNS—peripheral nervous system neoplasm	0.000166	0.00296	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NME1—peripheral nervous system neoplasm	0.000159	0.00284	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—BCHE—peripheral nervous system neoplasm	0.000156	0.00279	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ENO2—peripheral nervous system neoplasm	0.000156	0.00278	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	0.000155	0.00277	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—COX2—peripheral nervous system neoplasm	0.000153	0.00273	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—BCHE—peripheral nervous system neoplasm	0.000152	0.00272	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—BCHE—peripheral nervous system neoplasm	0.000152	0.00272	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000149	0.00266	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—TH—peripheral nervous system neoplasm	0.000147	0.00262	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000145	0.00259	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000145	0.00259	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TH—peripheral nervous system neoplasm	0.000143	0.00256	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TH—peripheral nervous system neoplasm	0.000143	0.00256	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—BCHE—peripheral nervous system neoplasm	0.000142	0.00254	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—BCHE—peripheral nervous system neoplasm	0.000142	0.00254	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000135	0.00242	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000135	0.00242	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TH—peripheral nervous system neoplasm	0.000133	0.00239	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TH—peripheral nervous system neoplasm	0.000133	0.00239	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—BCHE—peripheral nervous system neoplasm	0.000131	0.00235	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000125	0.00224	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ENO2—peripheral nervous system neoplasm	0.000124	0.00222	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TH—peripheral nervous system neoplasm	0.000124	0.00221	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GNAS—peripheral nervous system neoplasm	0.00012	0.00214	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000119	0.00213	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000118	0.0021	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GNAS—peripheral nervous system neoplasm	0.000117	0.00209	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GNAS—peripheral nervous system neoplasm	0.000117	0.00209	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000115	0.00205	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000115	0.00205	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000114	0.00204	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GNAS—peripheral nervous system neoplasm	0.000109	0.00195	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GNAS—peripheral nervous system neoplasm	0.000109	0.00195	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000107	0.00191	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000107	0.00191	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—BCHE—peripheral nervous system neoplasm	0.000105	0.00188	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000104	0.00185	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GNAS—peripheral nervous system neoplasm	0.000101	0.0018	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000101	0.0018	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ENO2—peripheral nervous system neoplasm	0.0001	0.00179	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.0001	0.00179	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ABCB1—peripheral nervous system neoplasm	9.9e-05	0.00177	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TH—peripheral nervous system neoplasm	9.86e-05	0.00176	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—BCHE—peripheral nervous system neoplasm	9.64e-05	0.00172	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.59e-05	0.00171	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TH—peripheral nervous system neoplasm	9.45e-05	0.00169	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.2e-05	0.00164	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TH—peripheral nervous system neoplasm	9.06e-05	0.00162	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—peripheral nervous system neoplasm	8.63e-05	0.00154	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—BCHE—peripheral nervous system neoplasm	8.47e-05	0.00152	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.33e-05	0.00149	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.17e-05	0.00146	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.08e-05	0.00145	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GNAS—peripheral nervous system neoplasm	8.05e-05	0.00144	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TH—peripheral nervous system neoplasm	7.97e-05	0.00142	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.9e-05	0.00141	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GNAS—peripheral nervous system neoplasm	7.72e-05	0.00138	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.57e-05	0.00135	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GNAS—peripheral nervous system neoplasm	7.4e-05	0.00132	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.26e-05	0.0013	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GNAS—peripheral nervous system neoplasm	6.5e-05	0.00116	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ABCB1—peripheral nervous system neoplasm	6.38e-05	0.00114	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—peripheral nervous system neoplasm	5.79e-05	0.00103	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.71e-05	0.00102	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—peripheral nervous system neoplasm	5.02e-05	0.000897	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.85e-05	0.000689	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—peripheral nervous system neoplasm	3.23e-05	0.000578	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—peripheral nervous system neoplasm	3.15e-05	0.000563	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—peripheral nervous system neoplasm	3.15e-05	0.000563	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—peripheral nervous system neoplasm	2.94e-05	0.000526	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—peripheral nervous system neoplasm	2.94e-05	0.000526	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.79e-05	0.000498	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—peripheral nervous system neoplasm	2.72e-05	0.000487	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.67e-05	0.000478	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.57e-05	0.00046	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—peripheral nervous system neoplasm	2.17e-05	0.000388	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—peripheral nervous system neoplasm	2.08e-05	0.000372	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—peripheral nervous system neoplasm	2e-05	0.000357	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—peripheral nervous system neoplasm	1.76e-05	0.000314	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.69e-05	0.000302	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.43e-05	0.000255	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.36e-05	0.000243	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.34e-05	0.00024	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.09e-05	0.000196	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.07e-05	0.000192	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.96e-06	5.28e-05	CbGpPWpGaD
